01.05.1999
Antibacterial Activity of Moxifloxacin (Bay 12-8039) against Aerobic Clinical Isolates, and Provisional Criteria for Disk Susceptibility Tests
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/1999
Einloggen, um Zugang zu erhalten